Iron-dextran anaphylactic-like reaction after a negative test dose and subsequent successful administration of three doses

Dialysis and Transplantation

Volumn 29, Issue 4, 2000, Pages 198-201

  Jayakumar, S ^a   Jayakumar, Shirley A ^b  

^a Gambro Healthcare Dialysis Clinic   (United States)

^b LAKE ERIE COLLEGE OF OSTEOPATHIC MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; DIPHENHYDRAMINE; ERYTHROPOIETIN; FERRIC GLUCONATE; FERRIC HYDROXIDE; HYDROCORTISONE SODIUM SUCCINATE; IRON DEXTRAN; IRON LECITHIN COMPLEX; LIDOCAINE;

AGED; ANAPHYLAXIS; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; HEMODIALYSIS; HUMAN; IRON DEFICIENCY ANEMIA; MALE; PRIORITY JOURNAL; RESUSCITATION; REVIEW; SKIN TEST;

EID: 0034081102     PISSN: 00902934     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (7)

1. Van Wyck D. Iron dextran in chronic renal failure. Semin Dial 1991; 4(2): 112-114.
2. Becker, MacGregor, Walker, Jandl. Fatal anaphylaxis after intramuscular iron dextran. Ann Intern Med 1966; 65(4):745-748.
3. Lewinter P. Iron dextran anaphylaxis. J Med Soc New Jersey 1967; 67(3):116-117.
4. Fishbane S, Ungureanu V, Maesaka J, Kaupuke C, Lim V, Wish J. The safety of intravenous iron dextran in hemodialysis patients Am J Kidney Dis 1996; 28:529-534.
5. Hanson, Hendeles. Guide to total dose intravenous iron dextran therapy. Am J Hosp Pharm 1974; 31:592-595.
6. NKF-DOQI™ Clinical Practice Guidelines for the Treatment of Anemia of Chronic Renal Failure. New York: National Kidney Foundation, 1997.
7. Package insert. Sodium ferric gluconate complex in sucrose injection (Ferrlecit®), Schein Pharmaceutical, Inc., 1998.